Why The Oncology Institute, Inc. (STLN) stock rose 15.2% intraday on Monday, November 9, 2026

The Oncology Institute, Inc. (STLN) traded at $4.17 as of 2:31 PM ET, up 15.19% on Monday, November 9, 2026, on volume of 6,713,707 shares (4.1× its 3-month average); market value about $400.0M.

STLN was among the stocks moving 5% or more in an earlier update that day; by the close it was no longer moving that much.

What happened: primary sources

Events Nexqual found for STLN on Monday, November 9, 2026 or the trading day before (November 6, 2026):

• Nov 6, 2026: SEC 10-Q: Quarterly report, period ended Sep 30, 2026 source
• Nov 9, 2026: BTIG: Reiterated, Buy, price target $10
• Nov 7, 2026: Lake Street: Target lowered, Buy, price target $10 → $8
• Nov 6, 2026: B. Riley Securities: Target lowered, Buy, price target $11 → $10
• Nov 6, 2026: BTIG: Target raised, Buy, price target $9 → $10

These are listed as context. A filing or rating change on the same day is not proof that it caused the move; read the source.

More on STLN

STLN stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. Other big moves that day: November 9, 2026.

Sources: SEC EDGAR, Nexqual Earnings Flash, analyst rating changes, Nexqual market data. Built November 10, 2026 at 16:24 UTC. Not investment advice.

Data source: Nexqual. Last updated: November 10, 2026 at 16:24 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt